Bayer HealthCare AG - Product Pipeline Analysis, 2016 Update
- December 2016
- 52 pages
- GlobalData
Summary
Table of Contents
Search Inside
Summary
Bayer HealthCare AG (Bayer Healthcare), a division of the Bayer Group, is a healthcare company. It designs, researches, develops, manufactures and sells pharmaceuticals and consumer health products. The company provides prescription pharmaceuticals, such as anticoagulants; treatments for cancer, hemophilia, multiple sclerosis, pulmonary hypertension, eye diseases, infectious diseases, high blood pressure and contraceptives; and over-the-counter (OTC) medications, nutritional supplements, dermatology products, veterinary medicines and animal grooming products, injection systems and contrast agents for diagnostic procedures. Bayer Healthcare markets its products across the world (including Europe, North America, Asia Pacific, Latin America, Africa and Middle East through regional and national distribution companies. Bayer Healthcare is headquartered in Leverkusen, Germany.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Bayer HealthCare AG
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 24h.
Our reports have been used by over 10K customers, including:
Get Industry Insights. Simply.
- Latest reports & slideshows with insights from top research analysts
- 60 Million searchable statistics with tables, figures & datasets
- More than 25,000 trusted sources
Veronica helps you find the right report:
- +1 718 514 2762
- Contact by email
Testimonials
The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.
Kate Merrick
Global Marketing Manager at
Eurotherm by Schneider Electric
We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.
Category Manager at
Ikea
ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.
Executive Director at
PwC Advisory
The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!
Scott Griffith
Vice President Marketing at
Maurice Sporting Goods
The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research
Jessica P Huffman
Research Associate at
American Transportation Research Institute
Excellent customer service. Very responsive and fast.
Director, Corporate Strategy at
Ingredion
I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.
Mariana Mendoza
Global Platform Senior Manager at
Whirlpool Corporation
Thanks! I like what you've provided and will certainly come back if I need to do further research works.
Bee Hin Png
CEO at
LDR Pte Ltd
The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.
Kate Merrick
Global Marketing Manager at
Eurotherm by Schneider Electric
Women%s Health Cluster Drug Development Pipeline Review, 2017
- $ 3995
- Company report
- May 2017
- by GBI Research
Women's Health Cluster Drug Development Pipeline Review, 2017 Summary This report provides an overview of the women’s health pipeline landscape. The report provides comprehensive information on the therapeutics ...
Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) - Pipeline Review, H2 2017
- $ 3500
- Company report
- July 2017
- by Global Markets Direct
Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) - Pipeline Review, H2 2017 Summary Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) ...
Irritable Bowel Syndrome - Pipeline Review, H1 2017
- $ 2000
- Company report
- May 2017
- by Global Markets Direct
Irritable Bowel Syndrome - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Irritable Bowel Syndrome - Pipeline Review, H1 2017, provides ...
More Reports:
Healthcare in the United States (4745)
Healthcare in World (6956)
Healthcare in Europe (3051)
Healthcare in Germany (2636)
Healthcare in Japan (2502)
Healthcare in France (2484)
Healthcare in Spain (2420)
Healthcare in Italy (2364)
Valeritas Holdings, Inc. - Quarterly Report, August 2017
- August 2017
24 pages
-
Insulin
-
United States
HealthSouth Corporation - Quarterly Report, August 2017
- August 2017
119 pages
-
Hospital
Nursing Home
-
United States
Healthcare Industry - Quarterly Report, August 2017
- August 2017
73 pages
-
Healthcare
Hospital
-
Puerto Rico
United States
North America
More Reports:
Healthcare in the United States (41971)
Healthcare in Australia (7669)
Healthcare in World (7034)
Healthcare in Europe (5769)
Healthcare in Canada (4630)
Healthcare in India (3637)
Healthcare in China (2978)
Healthcare in Africa (2898)
ref:plp2016
Reportlinker.com © Copyright 2017. All rights reserved.
